The future of NMR-based metabolomics

John L. Markley; Rafael Brüschweiler; Arthur S. Edison; Hamid R. Eghbalnia; Robert Powers; Daniel Raftery; David S. Wishart

doi:10.1016/j.copbio.2016.08.001

The future of NMR-based metabolomics

John L. Markley, Rafael Brüschweiler, Arthur S. Edison, Hamid R. Eghbalnia, Robert Powers, Daniel Raftery, David S. Wishart

Research output: Contribution to journal › Review article

281 Scopus citations

Abstract

The two leading analytical approaches to metabolomics are mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy. Although currently overshadowed by MS in terms of numbers of compounds resolved, NMR spectroscopy offers advantages both on its own and coupled with MS. NMR data are highly reproducible and quantitative over a wide dynamic range and are unmatched for determining structures of unknowns. NMR is adept at tracing metabolic pathways and fluxes using isotope labels. Moreover, NMR is non-destructive and can be utilized in vivo. NMR results have a proven track record of translating in vitro findings to in vivo clinical applications.

Original language	English (US)
Pages (from-to)	34-40
Number of pages	7
Journal	Current Opinion in Biotechnology
Volume	43
DOIs	https://doi.org/10.1016/j.copbio.2016.08.001
State	Published - Feb 1 2017

ASJC Scopus subject areas

Biotechnology
Bioengineering
Biomedical Engineering

Access to Document

10.1016/j.copbio.2016.08.001

Fingerprint Dive into the research topics of 'The future of NMR-based metabolomics'. Together they form a unique fingerprint.

Cite this

Markley, J. L., Brüschweiler, R., Edison, A. S., Eghbalnia, H. R., Powers, R., Raftery, D., & Wishart, D. S. (2017). The future of NMR-based metabolomics. Current Opinion in Biotechnology, 43, 34-40. https://doi.org/10.1016/j.copbio.2016.08.001

@article{a26bbb8352ef4fdbb36ccd304d7def98,

title = "The future of NMR-based metabolomics",

abstract = "The two leading analytical approaches to metabolomics are mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy. Although currently overshadowed by MS in terms of numbers of compounds resolved, NMR spectroscopy offers advantages both on its own and coupled with MS. NMR data are highly reproducible and quantitative over a wide dynamic range and are unmatched for determining structures of unknowns. NMR is adept at tracing metabolic pathways and fluxes using isotope labels. Moreover, NMR is non-destructive and can be utilized in vivo. NMR results have a proven track record of translating in vitro findings to in vivo clinical applications.",

author = "Markley, {John L.} and Rafael Br{\"u}schweiler and Edison, {Arthur S.} and Eghbalnia, {Hamid R.} and Robert Powers and Daniel Raftery and Wishart, {David S.}",

year = "2017",

month = feb,

day = "1",

doi = "10.1016/j.copbio.2016.08.001",

language = "English (US)",

volume = "43",

pages = "34--40",

journal = "Current Opinion in Biotechnology",

issn = "0958-1669",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - The future of NMR-based metabolomics

AU - Markley, John L.

AU - Brüschweiler, Rafael

AU - Edison, Arthur S.

AU - Eghbalnia, Hamid R.

AU - Powers, Robert

AU - Raftery, Daniel

AU - Wishart, David S.

PY - 2017/2/1

Y1 - 2017/2/1

N2 - The two leading analytical approaches to metabolomics are mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy. Although currently overshadowed by MS in terms of numbers of compounds resolved, NMR spectroscopy offers advantages both on its own and coupled with MS. NMR data are highly reproducible and quantitative over a wide dynamic range and are unmatched for determining structures of unknowns. NMR is adept at tracing metabolic pathways and fluxes using isotope labels. Moreover, NMR is non-destructive and can be utilized in vivo. NMR results have a proven track record of translating in vitro findings to in vivo clinical applications.

AB - The two leading analytical approaches to metabolomics are mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy. Although currently overshadowed by MS in terms of numbers of compounds resolved, NMR spectroscopy offers advantages both on its own and coupled with MS. NMR data are highly reproducible and quantitative over a wide dynamic range and are unmatched for determining structures of unknowns. NMR is adept at tracing metabolic pathways and fluxes using isotope labels. Moreover, NMR is non-destructive and can be utilized in vivo. NMR results have a proven track record of translating in vitro findings to in vivo clinical applications.

UR - http://www.scopus.com/inward/record.url?scp=84983486892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983486892&partnerID=8YFLogxK

U2 - 10.1016/j.copbio.2016.08.001

DO - 10.1016/j.copbio.2016.08.001

M3 - Review article

C2 - 27580257

AN - SCOPUS:84983486892

VL - 43

SP - 34

EP - 40

JO - Current Opinion in Biotechnology

JF - Current Opinion in Biotechnology

SN - 0958-1669

ER -